               SEQUENCE LISTING

<110> Academia Sinica

<120> METHOD FOR TREATING INFLUENZA A VIRUS INFECTION

<130> P2847-PCT

<160> 11

<170> BiSSAP 1.3

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> HBD Polynucleotide

<400> 1
ctgaagctgc gtcggcggct c                                              21


<210> 2
<211> 900
<212> DNA
<213> Artificial Sequence

<220> 
<223> DcR3 Polynucleotide

<400> 2
atgagggcgc tggaggggcc aggcctgtcg ctgctgtgcc tggtgttggc gctgcctgcc      60

ctgctgccgg tgccggctgt acgcggagtg gcagaaacac ccacctaccc ctggcgggac     120

gcagagacag gggagcggct ggtgtgcgcc cagtgccccc caggcacctt tgtgcagcgg     180

ccgtgccgcc gagacagccc cacgacgtgt ggcccgtgtc caccgcgcca ctacacgcag     240

ttctggaact acctggagcg ctgccgctac tgcaacgtcc tctgcgggga gcgtgaggag     300

gaggcacggg cttgccacgc cacccacaac cgtgcctgcc gctgccgcac cggcttcttc     360

gcgcacgctg gtttctgctt ggagcacgca tcgtgtccac ctggtgccgg cgtgattgcc     420

ccgggcaccc ccagccagaa cacgcagtgc cagccgtgcc ccccaggcac cttctcagcc     480

agcagctcca gctcagagca gtgccagccc caccgcaact gcacggccct gggcctggcc     540

ctcaatgtgc caggctcttc ctcccatgac accctgtgca ccagctgcac tggcttcccc     600

ctcagcacca gggtaccagg agctgaggag tgtgagcgtg ccgtcatcga ctttgtggct     660

ttccaggaca tctccatcaa gaggctgcag cggctgctgc aggccctcga ggccccggag     720

ggctggggtc cgacaccaag ggcgggccgc gcggccttgc agctgaagct gcgtcggcgg     780

ctcacggagc tcctgggggc gcaggacggg gcgctgctgg tgcggctgct gcaggcgctg     840

cgcgtggcca ggatgcccgg gctggagcgg agcgtccgtg agcgcttcct ccctgtgcac     900


<210> 3
<211> 684
<212> DNA
<213> Artificial Sequence

<220> 
<223> hIgG1.Fc Polynucleotide

<400> 3
gacaaaactc acacatgccc accgtgccca gcacccgaac tcctgggggg accgtcagtc      60

ttcctcttcc ccccaaaacc caaggacacc ctcatgatct cccggacccc tgaggtcaca     120

tgcgtggtgg tggacgtgag ccacgaagac cctgaggtca agttcaactg gtacgtggac     180

ggcgtggagg tgcataatgc caagacaaag ccgcgggagg agcagtacaa cagcacgtac     240

cgtgtggtca gcgtcctcac cgtcctgcac caggactggc tgaatggcaa ggagtacaag     300

tgcaaggtct ccaacaaagc cctcccagcc cccatcgaga aaaccatctc caaagccaaa     360

gggcagcccc gagaaccaca ggtgtacacc ctgcccccat cccgggatga gctgaccaag     420

aaccaggtca gcctgacctg cctggtcaaa ggcttctatc ccagcgacat cgccgtggag     480

tgggagagca atgggcagcc ggagaacaac tacaagacca cgcctcccgt gctggactcc     540

gacggctcct tcttcctcta cagcaagctc accgtggaca agagcaggtg gcagcagggg     600

aacgtcttct catgctccgt gatgcatgag gctctgcaca accactacac gcagaagagc     660

ctctccctgt ctccgggtaa atag                                            684


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> HBD Peptide

<400> 4
Leu Lys Leu Arg Arg Arg Leu 
1               5           

<210> 5
<211> 254
<212> PRT
<213> Artificial Sequence

<220> 
<223> DcR3-HBD Peptide

<400> 5
Met Arg Ala Leu Glu Gly Pro Gly Leu Ser Leu Leu Cys Leu Val Leu 
1               5                   10                  15      
Ala Leu Pro Ala Leu Leu Pro Val Pro Ala Val Arg Gly Val Ala Glu 
            20                  25                  30          
Thr Pro Thr Tyr Pro Trp Arg Asp Ala Glu Thr Gly Glu Arg Leu Val 
        35                  40                  45              
Cys Ala Gln Cys Pro Pro Gly Thr Phe Val Gln Arg Pro Cys Arg Arg 
    50                  55                  60                  
Asp Ser Pro Thr Thr Cys Gly Pro Cys Pro Pro Arg His Tyr Thr Gln 
65                  70                  75                  80  
Phe Trp Asn Tyr Leu Glu Arg Cys Arg Tyr Cys Asn Val Leu Cys Gly 
                85                  90                  95      
Glu Arg Glu Glu Glu Ala Arg Ala Cys His Ala Thr His Asn Arg Ala 
            100                 105                 110         
Cys Arg Cys Arg Thr Gly Phe Phe Ala His Ala Gly Phe Cys Leu Glu 
        115                 120                 125             
His Ala Ser Cys Pro Pro Gly Ala Gly Val Ile Ala Pro Gly Thr Pro 
    130                 135                 140                 
Ser Gln Asn Thr Gln Cys Gln Pro Cys Pro Pro Gly Thr Phe Ser Ala 
145                 150                 155                 160 
Ser Ser Ser Ser Ser Glu Gln Cys Gln Pro His Arg Asn Cys Thr Ala 
                165                 170                 175     
Leu Gly Leu Ala Leu Asn Val Pro Gly Ser Ser Ser His Asp Thr Leu 
            180                 185                 190         
Cys Thr Ser Cys Thr Gly Phe Pro Leu Ser Thr Arg Val Pro Gly Ala 
        195                 200                 205             
Glu Glu Cys Glu Arg Ala Val Ile Asp Phe Val Ala Phe Gln Asp Ile 
    210                 215                 220                 
Ser Ile Lys Arg Leu Gln Arg Leu Leu Gln Ala Leu Glu Ala Pro Glu 
225                 230                 235                 240 
Gly Trp Gly Pro Thr Pro Arg Ala Gly Arg Ala Ala Leu Gln 
                245                 250                 

<210> 6
<211> 39
<212> PRT
<213> Artificial Sequence

<220> 
<223> HBD-hIgG1.Fc Peptide

<400> 6
Thr Glu Leu Leu Gly Ala Gln Asp Gly Ala Leu Leu Val Arg Leu Leu 
1               5                   10                  15      
Gln Ala Leu Arg Val Ala Arg Met Pro Gly Leu Glu Arg Ser Val Arg 
            20                  25                  30          
Glu Arg Phe Leu Pro Val His 
        35                  

<210> 7
<211> 227
<212> PRT
<213> Artificial Sequence

<220> 
<223> hIgG1.Fc Peptide

<400> 7
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
1               5                   10                  15      
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
            20                  25                  30          
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His 
        35                  40                  45              
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
    50                  55                  60                  
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
65                  70                  75                  80  
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
                85                  90                  95      
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 
            100                 105                 110         
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val 
        115                 120                 125             
Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser 
    130                 135                 140                 
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu 
145                 150                 155                 160 
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro 
                165                 170                 175     
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val 
            180                 185                 190         
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met 
        195                 200                 205             
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser 
    210                 215                 220                 
Pro Gly Lys 
225         

<210> 8
<211> 26
<212> DNA
<213> Artificial Sequence

<220> 
<223> DcR3 primer-F

<400> 8
ggaattcaag gaccatgagg gcgctg                                         26


<210> 9
<211> 26
<212> DNA
<213> Artificial Sequence

<220> 
<223> DcR3 primer-R

<400> 9
ggaattcgtg cacagggagg aagcgc                                         26


<210> 10
<211> 39
<212> DNA
<213> Artificial Sequence

<220> 
<223> complementary sequence-1

<400> 10
aagcttgggc tgaagctgcg tcggcggctc gggaagctt                            39


<210> 11
<211> 39
<212> DNA
<213> Artificial Sequence

<220> 
<223> complementary sequence-2

<400> 11
aagcttcccg agccgccgac gcagcttcag cccaagctt                            39


